Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Human+ vs LunaRx

Human+
Graded #334

Lower grade

vs+1.4000000000000057
LunaRx
Graded #301

Higher grade

The verdict

LunaRx takes it — 61.2/100 to 59.8/100, but only just.

LunaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LunaRx is a bilingual (English/Spanish) telehealth practice from LunaRx LLC built around "metabolic recomposition" — compounded GLP-1 therapy paired with muscle-protective peptides and a structured off-ramp… Human+ is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLunaRx +9
45
54
Dose & formulationLunaRx +12
40
52
Clinical oversightHuman+ +1
83
82
Labs & monitoringHuman+ +12
66
54
FulfillmentHuman+ +20
90
70
Contract termsLunaRx +14
41
55
Human+ · left barLunaRx · right bar

The numbers

MetricHuman+LunaRx
WeighScore59.8/10061.2/100
GradeCC
Scorecard rank#334#301
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Human+

Graded #334 · C

Strengths

  • Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
  • Available via telehealth in all 50 states
  • Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
  • Fast, fully online 5-minute intake with provider review often within hours; discreet plain packaging
  • Covers weight loss plus hair, sexual wellness, mental health, and labs under one membership

Where it loses points

  • Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • LegitScript certification is shown only as a self-hosted badge; no verifiable LegitScript seal was found
  • Minimal public-facing site and a flat membership fee on top of the medication cost
LunaRx

Graded #301 · C

Strengths

  • Pairs GLP-1 with muscle-protective peptides (e.g., CJC-1295/Ipamorelin, NAD+) to defend lean mass during fat loss
  • Structured, physician-directed off-ramp taper with GI-reset support instead of an indefinite prescription
  • Bilingual care in English and Spanish across intake, messaging, and consults
  • Care directed through a named independent medical group (CareNexus Clinic PC); $0 charged if you are not approved
  • Published clinical support hours (Mon–Fri, CT) with phone, email, and secure messaging; cancel anytime

Where it loses points

  • Only a "from $199/mo" starting price is published; tirzepatide and per-tier pricing are confirmed only after a provider review
  • Compounding pharmacy partners are not named on the site — a transparency gap
  • No LegitScript or PCAB verification is displayed
  • States served are not published; the site claims "telehealth nationwide" but the Terms limit service to states where LunaRx is licensed
  • Compounded medications are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard